Alkyl Amines Chemicals Ltd. News and Updates

Name: Latest research reports of Alkyl Amines Chemicals Ltd. authored by HDFC Securities and published by - Trendlyne research reports.
Item: Alkyl Amines Chemicals Ltd.
Rating: 5
Author: HDFC Securities

Keep track of all breaking news on Alkyl Amines Chemicals Ltd. from all sources in a single place.

Load latest

Alkyl Amines Chemicals Ltd.

26 Mar 2021

1740.45

3.76%

Star SME: How Alkyl Amines Chemicals is tapping local, global demand

Business Standard

Large capacities and efficient use of capital have been key to Alkyl Amines Chemicals' profitable growth

Number of FII/FPI investors decreased from 111 to 105 in Dec 2024 qtr

Alkyl Amines Chemicals Ltd.

23 Mar 2021

1740.45

3.76%

Alkyl Amines surges 12%, hits fresh high ahead of stock split

Business Standard

The company got the shareholders' approval for the sub division of face value of equity shares from Rs 5 to Rs 2

Motilal Oswal decreased Neutral price target of Alkyl Amines Chemicals Ltd. to 1610.0 on 09 Apr, 2025.

Alkyl Amines Chemicals Ltd.

05 Jan 2021

1740.45

3.76%

Alkyl Amines Chemicals Zooms Nearly 12% On Stock-Split Plans

NDTV Profit

"The board of directors of the company are scheduled to meet on February 2 to consider the proposal of sub-division of equity shares from the face value of Rs 5 to a lower denomination," the...

Alkyl Amines Chemica.. has an average target of 1610.00 from 1 broker.

Alkyl Amines Chemicals Ltd.

04 Jan 2021

1740.45

3.76%

Alkyl Amines Chemicals advances 7% on stock split, expansion plan

Business Standard

The company plans to go for a stock split to make shares more affordable for small retail investors and increase liquidity

Motilal Oswal decreased Neutral price target of Alkyl Amines Chemicals Ltd. to 1610.0 on 09 Apr, 2025.

Alkyl Amines Chemicals Ltd.

19 Aug 2020

1740.45

3.76%

Buy Alkyl Amines; target of Rs 3355: HDFC Securities

Moneycontrol

HDFC Securities is bullish on Alkyl Amines has recommended buy rating on the stock with a target price of Rs 3355 in its research report dated August 17, 2020.

Alkyl Amines Chemicals Ltd. is trading above its 50 day SMA of 1679.9

Alkyl Amines Chemicals Ltd.

18 Aug 2020

1740.45

3.76%

Balaji Amnies, Alkyl Amines: Specialty chemical stocks have more steam left

Business Standard

Major specialty chemical stocks exhibit strong strength on good volumes. Here are the key levels for frontline stocks from this sector.

Alkyl Amines Chemicals Ltd. has lost -24.34% in the last 6 Months

Alkyl Amines Chemicals Ltd.

26 Jun 2020

1740.45

3.76%

Buy Alkyl Amines; target of Rs 2500: HDFC Securities

Moneycontrol

HDFC Securities is bullish on Alkyl Amines has recommended buy rating on the stock with a target price of Rs 2500 in its research report dated June 26, 2020.

Number of FII/FPI investors decreased from 111 to 105 in Dec 2024 qtr

Alkyl Amines Chemicals Ltd.

06 Feb 2020

1740.45

3.76%

Advanced Enzyme, Alkyl Amines gain 4-7% on better Q3 show

Moneycontrol

Alkyl Amines has registered 172 percent jump in its Q3 consolidated net profit at Rs 60.4 crore versus Rs 22.2 crore, YoY.

Alkyl Amines Chemicals Ltd. is trading above its 50 day SMA of 1679.9

Alkyl Amines Chemicals Ltd.

10 Jan 2020, 02:43PM

1740.45

3.76%

Oil & Gas, Chemicals: 3QFY20E Results Preview

Buy: Alkyl Amines Chemicals Ltd.

Target

HDFC Securities

Chemicals: Alkyl Amines stands out Oil & Gas: CGD to shine

Alkyl Amines Chemicals Ltd. is trading above its 50 day SMA of 1679.9

Alkyl Amines Chemicals Ltd.

08 Nov 2019

1740.45

3.76%

Alkyl Amines (2QFY20): Forward march. Maintain BUY

Buy: Alkyl Amines Chemicals Ltd.

Target

HDFC Securities

(1) Backed by robust demand by the Pharma industry, (2) 15kTPA capacity addition of Methyl Amines at Dahej, and (3) Enhanced Acetonitrile capacity by 15kTPA to 33, will help AACL garner market share. With strong return ratios (RoIC of >25% over FY20-22E) and attractive valuations (trading at 13.3/11.6 FY21/22E EPS), Alkyl Amines is our top pick in the Chemicals space. We maintain BUY on AACL post a beat on our EBITDA estimates in 1HFY20. We bump-up our EBITDA margins by ~200-300bps over FY20-22 to factor in AACLs enhanced bargaining power and improved product mix. Our revised target price is Rs 1,770 (22x Sep-FY21 EPS).